Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 2/2007

01-02-2007 | Letter To the Editor

Syndrome of inappropriate secretion of ADH after administration of intrathecal chemotherapy in acute promyelocytic leukemia with empty sella of pituitary gland

Authors: Yutaka Tsutsumi, Takahito Kawamura, Souichi Shiratori, Shinobu Mashiko, Makoto Ibata, Akio Mori, Junji Tanaka, Masahiro Asaka, Masahiro Imamura, Nobuo Masauzi

Published in: Annals of Hematology | Issue 2/2007

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Milionis HJ, Liamis GL, Elisaf MS (2002) The hyponatremic patient: a systematic approach to laboratory diagnosis. CMAJ 166:1056–1062PubMed
2.
Slater LM, Wainer RA, Serpick AA (1969) Vincristine neurotoxity with hyponatremia. Cancer 23:122–125PubMedCrossRef
3.
Harlow PJ, DeClerck YA, Shore NA, Carranza A, Heuser E (1979) A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy. Cancer 44:896–898PubMedCrossRef
4.
Sorensen JB, Anderson MK, Hansen HH (1995) Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med 238:97–110PubMedCrossRef
5.
Rudnick SA, Cadman EC, Capizzi RL, Skeel RT, Bertino JR, Mcintosh S (1979) High dose cytosine arabinoside (HDARAC) in refractory acute leukemia. Cancer 44:1189–1193PubMedCrossRef
Metadata
Title
Syndrome of inappropriate secretion of ADH after administration of intrathecal chemotherapy in acute promyelocytic leukemia with empty sella of pituitary gland
Authors
Yutaka Tsutsumi
Takahito Kawamura
Souichi Shiratori
Shinobu Mashiko
Makoto Ibata
Akio Mori
Junji Tanaka
Masahiro Asaka
Masahiro Imamura
Nobuo Masauzi
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 2/2007
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-006-0199-9

Other articles of this Issue 2/2007

Annals of Hematology 2/2007 Go to the issue

Original Article

Results of a national consensus workshop: therapeutic algorithm in patients with follicular lymphoma—role of radioimmunotherapy

Original Article

High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study

Original Article

Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma

Letter to the Editor

Hepatosplenic alpha/beta T cell lymphoma presenting with cold agglutinin disease

Original Article

The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma

Letter to the Editor

Arsenic trioxide induced acute flare-up of rheumatoid arthritis in a patient with APL
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits